Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
RESEARCH TOOLSreports
Holding ZNTL?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 09, 2024 | xxxxxxxxxxxxx | $42353 | |
| Feb 05, 2024 | Andrea Paul Clo | xxxxxxxxxxxxx | $38197 |
| Feb 05, 2024 | Mark Lackner Cso | xxxxxxxxxxxxx | $18291 |
| Nov 13, 2023 | David Michael Johnson Director | xxxxxxxxxxxxx | $167790 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $18354253 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $22647529 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,959,973 | Institution | 19.66% | 55,421,093 | |
| 11,557,422 | Institution | 16.28% | 45,882,965 | |
| 4,179,634 | Institution | 5.89% | 16,593,147 | |
| 3,710,297 | Institution | 5.22% | 14,729,879 | |
| 2,819,664 | Institution | 3.97% | 11,194,066 | |
| 2,618,242 | Institution | 3.69% | 10,394,421 | |
| 2,108,364 | Institution | 2.97% | 8,370,205 | |
| 1,975,000 | Institution | 2.78% | 7,840,750 | |
| 1,767,897 | Institution | 2.49% | 7,018,551 | |
| 1,462,933 | Institution | 2.06% | 5,807,844 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,557,422 | Institution | 16.28% | 45,882,965 | |
| 3,710,297 | Institution | 5.22% | 14,729,879 | |
| 2,819,664 | Institution | 3.97% | 11,194,066 | |
| 2,108,364 | Institution | 2.97% | 8,370,205 | |
| 1,975,000 | Institution | 2.78% | 7,840,750 | |
| 1,462,933 | Institution | 2.06% | 5,807,844 | |
| 1,427,454 | Institution | 2.01% | 5,666,992 | |
| 1,256,676 | Institution | 1.77% | 4,989,004 | |
| 1,230,128 | Institution | 1.73% | 4,883,608 | |
| 1,227,156 | Institution | 1.73% | 4,871,809 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,260,987 | Institution | 1.78% | 14,980,526 | |
| 992,469 | Institution | 1.40% | 11,790,532 | |
| 865,795 | Institution | 1.22% | 10,285,645 | |
| 1,694,610 | Institution | 2.39% | 6,744,548 | |
| 565,903 | Institution | 0.80% | 6,722,928 | |
| 1,414,677 | Institution | 1.99% | 5,630,414 | |
| 217,569 | Institution | 0.31% | 2,584,720 | |
| 179,455 | Institution | 0.25% | 2,131,925 | |
| 531,171 | Institution | 0.75% | 2,114,061 | |
| 454,381 | Institution | 0.64% | 1,803,893 |
FAQ
Who Owns Zentalis Pharmaceuticals (ZNTL)?
Currently, no data Available
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors?
Currently, no data Available
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Zentalis Pharmaceuticals (ZNTL)?
Christopher J. Burke owns the most shares of Zentalis Pharmaceuticals (ZNTL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.